Antibody responses to single‐dose SARS‐CoV‐2 vaccination in patients receiving immunomodulators for immune‐mediated inflammatory disease-Reference-Cited by-同舟云学术

Antibody responses to single‐dose SARS‐CoV‐2 vaccination in patients receiving immunomodulators for immune‐mediated inflammatory disease

Published:2021-06-04 Issue:3 Volume:185 Page:646-648
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Al‐Janabi A.¹^ORCID,Littlewood Z.¹,Griffiths C.E.M.¹^ORCID,Hunter H.J.A.¹,Chinoy H.²³⁴^ORCID,Moriarty C.⁵,Yiu Z.Z.N.¹^ORCID,Warren R.B.¹^ORCID

Affiliation:

1. Dermatology Centre Salford Royal NHS Foundation Trust Manchester NIHR Biomedical Research Centre The University of Manchester Manchester M6 8HD UK

2. National Institute for Health Research, Manchester Biomedical Research Centre Manchester University NHS Foundation Trust The University of Manchester Manchester UK

3. Department of Rheumatology Salford Royal NHS Foundation Trust Manchester Academic Health Science Centre Salford UK

4. Centre for Musculoskeletal Research Faculty of Biology, Medicine and Health The University of Manchester Manchester UK

5. Affinity Biomarker Labs, Translation & Innovation Hub Building Imperial College London White City Campus London W12 0BZ UK

Funder

Psoriasis Association

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjd.20479

Reference7 articles.

1. Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals

2. AngyalA LongetS MooreSet al.T‐cell and antibody responses to first BNT162b2 vaccine dose in previously SARS‐CoV‐2‐infected and infection‐naive UK healthcare workers: a multicentre prospective observational cohort study. Available at:https://doi.org/10.2139/ssrn.3812375(preprint).

3. T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial

4. Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

5. Antibody Responses after a Single Dose of SARS-CoV-2 mRNA Vaccine

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PsoBioVax: A multicentric Italian case–control study of the immunological response to anti‐SARS‐CoV‐2 vaccine among psoriatic patients under biological therapy;Journal of the European Academy of Dermatology and Venereology;2023-12-07

2. COVID-19 Vaccination and Immunosuppressive Therapy in Immune-Mediated Inflammatory Diseases;Vaccines;2023-12-04

3. The 2023 Impact of Inflammatory Bowel Disease in Canada: Special Populations—IBD in Seniors;Journal of the Canadian Association of Gastroenterology;2023-09-01

4. ЕГДЕ ЖАСТАҒЫ АДАМДАРДА COVID-19 ВАКЦИНАЦИЯСЫНЫҢ ТИІМДІЛІГІ;Vestnik;2023-08-18

5. COVID-19 vaccination in psoriasis patients receiving systemic treatment: A prospective single-center study;Frontiers in Immunology;2023-03-16